Carbon monoxide form of PEGylated hemoglobin protects myocardium against ischemia/reperfusion injury in diabetic and normal mice

References

• Aleshin A, Ananthakrishnan R, Li Q, Rosario R, Lu Y, Qu W, et al. 2008. RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model. Am J Physiol Heart Circ Physiol. 294:H1823–832.
   Google Scholar
• Ananthakrishnan R, Kaneko M, Hwang YC, Quadri N, Gomez T, Li Q, et al. 2009. Aldose reductase mediates myocardial ischemia- reperfusion injury in part by opening mitochondrial permeability transition pore. Am J Physiol Heart Circ Physiol. 296:H333–341.
   PubMed Web of Science ®Google Scholar
• Bilban M, Haschemi A, Wegiel B, Chin BY, Wagner O, Otterbein LE. 2008. Heme oxygenase and carbon monoxide initiate homeostatic signaling. J Mol Med (Berl). 86:267–279.
   PubMed Web of Science ®Google Scholar
• Bobofchak KM, Mito T, Texel SJ, Bellelli A, Nemoto M, Traystman RJ, et al. 2003. A recombinant polymeric hemoglobin with conformational, functional, and physiological characteristics of an in vivo O2 transporter. Am J Physiol Heart Circ Physiol. 285:H549–561.
   PubMed Web of Science ®Google Scholar
• Cabrales P, Tsai AG, Intaglietta M. 2007. Deferoxamine lowers tissue damage after 80% exchange transfusion with polymerized hemoglobin. Antioxid Redox Signal. 9:375–384.
   Google Scholar
• Capellini VK, Celotto AC, Baldo CF, Olivon VC, Viaro F, Rodrigues AJ, Evora PR. 2010. Diabetes and vascular disease: basic concepts of nitric oxide physiology, endothelial dysfunction, oxidative stress and therapeutic possibilities. Curr Vasc Pharmacol. 8:526–544.
   Google Scholar
• Cheng X, Siow RC, Mann GE. 2011. Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway. Antioxid Redox Signal. 14:469–487.
   PubMed Web of Science ®Google Scholar
• Chin BY, Jiang G, Wegiel B, Wang HJ, Macdonald T, Zhang XC, et al. 2007. Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci USA. 104:5109–5114.
   PubMed Web of Science ®Google Scholar
• Clark JE, Naughton P, Shurey S, Green CJ, Johnson TR, Mann BE, et al. 2003. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res. 93:e2–8.
   PubMed Web of Science ®Google Scholar
• Cole DJ, Drummond JC, Patel PM, Reynolds LR. 1997. Hypervolemic-hemodilution during cerebral ischemia in rats: effect of diaspirin cross-linked hemoglobin (DCLHb) on neurologic outcome and infarct volume. J Neurosurg Anesthesiol. 9:44–50.
   PubMed Web of Science ®Google Scholar
• Conover CD, Lejeune L, Shum K, Gilbert C, Shorr RG. 1997. Physiological effect of polyethylene glycol conjugation on stroma-free bovine hemoglobin in the conscious dog after partial exchange transfusion. Artif Organs. 21:369–378.
   PubMed Web of Science ®Google Scholar
• Conover CD, Malatesta P, Lejeune L, Chang CL, Shorr RG. 1996. The effects of hemodilution with polyethylene glycol bovine hemoglobin (PEG-Hb) in a conscious porcine model. J Investig Med. 44:238–246.
   PubMed Web of Science ®Google Scholar
• Dawn B, Bolli R. 2005. HO-1 induction by HIF-1: a new mechanism for delayed cardioprotection?Am J Physiol Heart Circ Physiol. 289:H522–524.
   PubMed Web of Science ®Google Scholar
• Dong DL, Zhang Y, Lin DH, Chen J, Patschan S, Goligorsky MS, et al. 2007. Carbon monoxide stimulates the Ca2(+)-activated big conductance k channels in cultured human endothelial cells. Hypertension. 50:643–651.
   Google Scholar
• Dunne JR, Malone D, Tracy JK, Gannon C, Napolitano LM. 2002. Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res. 102:237–244.
   PubMed Web of Science ®Google Scholar
• Dunne JR, Malone DL, Tracy JK, Napolitano LM. 2004. Allogenic blood transfusion in the first 24 hours after trauma is associated with increased systemic inflammatory response syndrome (SIRS) and death. Surg Infect (Larchmt). 5:395–404.
   PubMedGoogle Scholar
• Francia P, Cosentino F, Schiavoni M, Huang Y, Perna E, Camici GG, et al. 2009. p66(Shc) protein, oxidative stress, and cardiovascular complications of diabetes: the missing link. J Mol Med (Berl). 87:885–891.
   Google Scholar
• Hwang YC, Kaneko M, Bakr S, Liao H, Lu Y, Lewis ER, et al. 2004. Central role for aldose reductase pathway in myocardial ischemic injury. FASEB J. 18:1192–1199.
   PubMed Web of Science ®Google Scholar
• Intaglietta M. 1999. Microcirculatory basis for the design of artificial blood. Microcirculation. 6:247–258.
   PubMed Web of Science ®Google Scholar
• Klaus JA, Kibler KK, Abuchowski A, Koehler RC. 2010. Early treatment of transient focal cerebral ischemia with bovine PEGylated carboxy hemoglobin transfusion. Artif Cells Blood Substit Immobil Biotechnol. 38:223–229.
   PubMed Web of Science ®Google Scholar
• Matheson B, Kwansa HE, Bucci E, Rebel A, Koehler RC. 2002. Vascular response to infusions of a nonextravasating hemoglobin polymer. J Appl Physiol. 93:1479–1486.
   PubMed Web of Science ®Google Scholar
• Mito T, Nemoto M, Kwansa H, Sampei K, Habeeb M, Murphy SJ, et al. 2009. Decreased damage from transient focal cerebral ischemia by transfusion of zero-link hemoglobin polymers in mouse. Stroke. 40:278–284.
   PubMed Web of Science ®Google Scholar
• Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, Green CJ. 2002. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res. 90:E17–24.
   PubMed Web of Science ®Google Scholar
• Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM. 2008. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA. 299:2304–2312.
   PubMed Web of Science ®Google Scholar
• Natarajan R, Salloum FN, Fisher BJ, Kukreja RC, Fowler AA III. 2006. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury. Circ Res. 98:133–140.
   PubMed Web of Science ®Google Scholar
• Nemoto M, Mito T, Brinigar WS, Fronticelli C, Koehler RC. 2006. Salvage of focal cerebral ischemic damage by transfusion of high O2-affinity recombinant hemoglobin polymers in mouse. J Appl Physiol. 100:1688–1691.
   PubMed Web of Science ®Google Scholar
• Nho K, Glower D, Bredehoeft S, Shankar H, Shorr R, Abuchowski A. 1992. PEG-bovine hemoglobin: safety in a canine dehydrated hypovolemic-hemorrhagic shock model. Biomater Artif Cells Immobilization Biotechnol. 20:511–524.
   PubMed Web of Science ®Google Scholar
• Nucci ML, Shorr RGL, Abuchowski A. 1996. PEG-hemoglobin oxygen carrying blood substitute. Drugs Future. 21:29–32.
   Google Scholar
• Ockaili R, Natarajan R, Salloum F, Fisher BJ, Jones D, Fowler AA III, Kukreja RC. 2005. HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. Am J Physiol Heart Circ |Physiol. 289:H542–548.
   PubMed Web of Science ®Google Scholar
• Sammut IA, Foresti R, Clark JE, Exon DJ, Vesely MJ, Sarathchandra P, et al. 1998. Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1. Br J Pharmacol. 125:1437–1444.
   PubMed Web of Science ®Google Scholar
• Saxena R, Wijnhoud AD, Carton H, Hacke W, Kaste M, Przybelski RJ, et al. 1999. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke. 30:993–996.
   PubMed Web of Science ®Google Scholar
• Silverman TA, Weiskopf RB. 2009. Hemoglobin-based oxygen carriers: current status and future directions. Transfusion. 49:2495–2515.
   PubMed Web of Science ®Google Scholar
• Small EM, Thatcher JE, Sutherland LB, Kinoshita H, Gerard RD, Richardson JA, et al. 2010. Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ Res. 107:294–304.
   PubMed Web of Science ®Google Scholar
• Stein AB, Guo Y, Tan W, Wu WJ, Zhu X, Li Q, et al. 2005. Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. J Mol Cell Cardiol. 38:127–134.
   PubMed Web of Science ®Google Scholar
• Tsai AG, Acero C, Nance PR, Cabrales P, Frangos JA, Buerk DG, Intaglietta M. 2005. Elevated plasma viscosity in extreme hemodilution increases perivascular nitric oxide concentration and microvascular perfusion. Am J Physiol Heart Circ Physiol. 288:H1730–1739.
   Web of Science ®Google Scholar
• Tsai AG, Cabrales P, Manjula BN, Acharya SA, Winslow RM, Intaglietta M. 2006. Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers. Blood. 108:3603–3610.
   PubMed Web of Science ®Google Scholar
• Van den Oever IA, Raterman HG, Nurmohamed MT, Simsek S. 2010. Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus. Mediators Inflamm. 2010:792393.
   PubMed Web of Science ®Google Scholar
• Vandegriff KD, Young MA, Lohman J, Bellelli A, Samaja M, Malavalli A, Winslow RM. 2008. CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats. Br J Pharmacol. 154:1649–1661.
   PubMed Web of Science ®Google Scholar
• Wettstein R, Tsai AG, Erni D, Winslow RM, Intaglietta M. 2003. Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters. Crit Care Med. 31:1824–1830.
   PubMed Web of Science ®Google Scholar
• Yellon DM, Downey JM. 2003. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev. 83: 1113–1151.
   PubMed Web of Science ®Google Scholar
• Young MA, Malavalli A, Winslow N, Vandegriff KD, Winslow RM. 2007. Toxicity and hemodynamic effects after single dose administration of MalPEG-hemoglobin (MP4) in rhesus monkeys. Transl Res. 149:333–342.
   PubMed Web of Science ®Google Scholar